Literature DB >> 9529415

ABC of allergies. Pathogenic mechanisms: a rational basis for treatment.

P H Howarth1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529415      PMCID: PMC1112728          DOI: 10.1136/bmj.316.7133.758

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Cetirizine: a review of its use in children with allergic disorders.

Authors:  C M Spencer; S Noble
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

Review 2.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.

Authors:  K Simpson; B Jarvis
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.

Authors:  Keri Wellington; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Pathophysiology of nasal congestion.

Authors:  Robert M Naclerio; Claus Bachert; James N Baraniuk
Journal:  Int J Gen Med       Date:  2010-04-08

6.  Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa.

Authors:  Sachiko Mori; Ruby Pawankar; Chika Ozu; Manabu Nonaka; Toshiaki Yagi; Kimihiro Okubo
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-12       Impact factor: 5.764

7.  Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.

Authors:  Toshiyuki Shimizu; Kenichi Kanai; Kazuhito Asano; Tadashi Hisamitsu; Harumi Suzaki
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.